General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

"Pfizer just released its list of side effects of its COVID-19 vaccine," multiple Facebook posts said Jan. 26 and 27. The posts included a purported list of 46 Pfizer-BioNtech COVID-19 vaccine side ...

According to Pfizer and BioNTech, this is the first time that an mRNA-based flu vaccine has started a phase 3 efficacy trial. Its rival Moderna said earlier this month, however, that it has ...

Aside from Pfizer, other companies were also asked if they expect any changes from the incoming administration on vaccines. The CEO of Moderna, which created the mRNA Covid vaccine, and has other ...

Moderna launched RSV vaccine mResvia in 2024 as the third-to-market product behind GSK and Pfizer vaccines. However, the firm's pipeline progress could lead to 2025-27 launches for a covid/flu ...

Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. (Photo by: Plexi ... [+] Images/GHI/UCG/Universal Images Group via Getty Images) The stock price of Moderna saw a 12% jump on ...

Moderna launched its RSV vaccine last year, following earlier approved vaccines from Pfizer (PFE) and GSK (GSK). A health worker prepares a Moderna COVID-19 vaccine at a vaccination center.

Moderna stock gained 14%, shooting up to $48.56 per share Tuesday afternoon. Vaccine-makers Novavax and CureVac similarly rose, soaring 15% and 10%, respectively, while Pfizer gained 2% and GSK ...

Vaccine makers' stocks surged on Tuesday after the US reported its first bird flu death. Moderna, Novavax, and CureVac saw double-digit gains, while Pfizer and GSK also rose. The drugmakers have ...